Privia Health Group, Inc. is a population health technology and medical practice management company in the United States.
| Revenue (TTM) | $2.43B |
| Gross Profit (TTM) | $241.19M |
| EBITDA | $63.81M |
| Operating Margin | 3.13% |
| Return on Equity | 4.72% |
| Return on Assets | 2.19% |
| Revenue/Share (TTM) | $19.44 |
| Book Value | $6.40 |
| Price-to-Book | 3.75 |
| Price-to-Sales (TTM) | 1.28 |
| EV/Revenue | 1.077 |
| EV/EBITDA | 41.08 |
| Quarterly Earnings Growth (YoY) | 100.00% |
| Quarterly Revenue Growth (YoY) | 13.20% |
| Shares Outstanding | $127.73M |
| Float | $108.78M |
| % Insiders | 6.19% |
| % Institutions | 100.33% |
Volatility is currently expanding
Privia Health Group NASDAQ: PRVA raised its 2026 financial outlook after reporting growth in providers, patient attribution and adjusted earnings through the first nine months of the year. The company also announced a $36 million acquisition that will expand its Medicare value-based care footprint in 2027.
Privia Health Group, Inc. (PRVA) Q3 2026 Earnings Call Transcript
The headline numbers for Privia Health (PRVA) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Privia Health (PRVA) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago.
Privia Health Reports Strong Q3 and YTD 2026 Results - Adjusted EBITDA of $114.7M, +21.9% from YTD'25 – FY'26 Guidance Raised for All Key Financial Metrics
ARLINGTON, Va., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the acquisition of American Choice Healthcare MSSP, LLC (ACH), a wholly-owned subsidiary of Cano Health.
Privia Health Group is rated BUY, supported by strong operating leverage and expanding value-based care, positioning for earnings upside. PRVA trades at a 48% discount to its five-year average forward EV/EBITDA, with 24% forward EBITDA growth, outpacing peers. 2Q26 results showed 15% care margin growth, 29% adjusted EBITDA growth, and robust provider and patient expansion, highlighting operating efficiency.
ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D.
Privia Health Group NASDAQ: PRVA reported second-quarter results marked by double-digit growth in implemented providers, attributed lives and practice collections, while adjusted EBITDA rose 29% from a year earlier. Management also raised its 2026 outlook for several financial measures following what Chief Executive Officer Parth Mehrotra described as strong first-half execution.
Privia Health Group, Inc. (PRVA) Q2 2026 Earnings Call Transcript
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PRVA and any ticker you trade — then tracks every position and per-strategy win rate.
